Karnataka Reports 87 New Covid-19 Cases, Active Count Crosses 300-Mark
Over the past 24 hours, over 504 individuals were tested, and 29 patients were discharged.
Karnataka's Health and Family Welfare Department announced that the state's active COVID-19 cases have surpassed 300. As schools reopened on Monday following the summer break, health authorities are maintaining high alert across the state.
According to the department, the total number of active COVID-19 cases stands at 311, with 87 new cases reported in the past 24 hours. During this period, 504 individuals were tested, and 29 patients were discharged. The COVID-19 positivity rate was reported at 17.2 percent, with the case fatality rate remaining at zero.
Among the active cases, 297 patients are in home quarantine, while 14 are hospitalized, including three who are in intensive care units of both government and private hospitals. Bengaluru continues to be the state's hotspot, with the majority of active cases reported from the city.
In addition to COVID-19, there is growing concern over the rise in Severe Acute Respiratory Infection (SARI) and influenza cases. Since January, Karnataka has recorded 4,536 cases of SARI and influenza, with 154 cases reported in the past week alone. Health officials have observed a steep upward trend in such cases and are conducting COVID-19 tests for patients showing related symptoms.
Doctors have advised the public to remain vigilant and not ignore symptoms such as fever, cough, fatigue, nasal congestion, runny nose, headache, breathing difficulties, and throat pain.
First Published:
June 03, 2025, 08:03 IST
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
22 minutes ago
- New Indian Express
Pharmacist association urges CM Majhi for early recruitment of heath workers
BHUBANESWAR: The Odisha Registered Pharmacist Association (ORPA) has appealed to Chief Minister Mohan Charan Majhi to direct the Health and Family Welfare department to expedite the recruitment of pharmacy officers and multipurpose male health workers. In a memorandum to the chief minister, the association claimed that though the state government had notified 1,657 posts, including 1,451 pharmacy officers and 206 multipurpose male health workers in 2023, their recruitment hangs in balance. The association members said the Odisha Sub-ordinate Staff Selection Commission (OSSSC) had received applications for the notified posts in December, 2023 and the computer-based test (CBT) was conducted on August 3, 2024. Although the results were published on June 16 this year along with the list of selected candidates along with the district of their choice, they are yet to get the appointment letter. ORPA general secretary Sabyasachi Panda said even though two months have passed since the results of the final examination were announced, the government has not issued appointment letters to the selected candidates. 'The candidates have already lost two years in the recruitment process. The government should immediately issue appointment letters without any further delay,' he said. The association has also requested Health minister Mukesh Mahaling to take steps in this regard.
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
Pfizer share price up 3% on rolling out this vaccine; key details inside
Pfizer share price: Pharmaceutical company Pfizer shares were in focus on Tuesday, August 12, 2025, with the stock rising up to 2.92 per cent to an intraday high of ₹5,188 per share. At 9:45 AM, Pfizer shares were trading 2.66 per cent higher at ₹5,175 per share. By comparison, BSE Sensex was trading 0.25 per cent higher at 80,802.18 levels. Why did Pfizer share price rise today? Pfizer's share price gained today after the company announced the launch of its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India. Offering broader serotype coverage, the vaccine represents a major step forward in protecting against pneumococcal disease. PCV20 provides immunity against 20 clinically major serotypes that cause the majority of invasive and non-invasive pneumococcal infections. Meenakshi Nevatia, managing director, Pfizer India, said, 'We are excited to launch PCV20, our 20-valent pneumococcal conjugate vaccine, in India. We believe this vaccine, with its broad coverage of 20 pneumococcal disease serotypes, will address the increasing need for adult immunisation in our country.' Additionally, it will be available as a single-dose vaccine, potentially eliminating the need for a second shot, and is suitable for all adults, including those with chronic health conditions, the company revealed, in a statement. Adults over 50, along with individuals suffering from comorbidities such as asthma, COPD, chronic kidney disease, and diabetes, are at higher risk of contracting pneumococcal infections, which can lead to serious complications, hospitalisations, or death. Timely immunisation is considered crucial to lowering these risks. Pneumococcal conjugate vaccines are among the most effective public health measures for reducing the incidence and severity of pneumococcal disease. The launch of PCV20 in India reinforces Pfizer's 25-year track record in pneumococcal vaccine innovation and its ongoing commitment to preventive healthcare. About Pfizer Pfizer is a globally recognised biopharmaceutical company with a legacy spanning more than 170 years. Headquartered in New York City, the company is dedicated to discovering, developing, and delivering medical breakthroughs that improve lives. With operations in over 125 countries, Pfizer plays a critical role in advancing global health through a diverse range of innovative treatments and vaccines. In India, Pfizer has a strong presence, including a state-of-the-art manufacturing facility in Goa that supports both local and international supply chains. The company's work spans key therapeutic areas such as vaccines, oncology, internal medicine, and rare diseases. Pfizer is a leader in vaccine development, notably using mRNA technology in its Covid-19 vaccine. Its oncology division focuses on cutting-edge cancer treatments, while internal medicine offerings address chronic conditions like diabetes and heart disease. Pfizer also invests in rare disease research and provides popular over-the-counter products like Advil, Nexium, Centrum, and ChapStick.
Time of India
5 hours ago
- Time of India
Myths about mRNA Vaccines: Separating facts from fiction
From wild claims that they can alter your DNA to worries about 'turbo cancer' and vaccine shedding, most of us have seen sensational headlines about mRNA vaccines. These ideas, no matter how impressive they are, often leave us with a plethora of confusion. Can the vaccines really alter DNA? Or can it trigger turbo cancer? What really are the aftereffects of the vaccines? Here's the truth: mRNA vaccines do not change your DNA, do not cause aggressive cancers, and do not emit anything that harms others. Trusted health organizations, scientists, and regulators have thoroughly debunked these myths. And now, we're here with this guide to help you understand what's true and what's not. Busting mRNA vaccine myths : One scientific fact at a time Myth 1: mRNA shots alter your DNA This myth is at the heart of many fears. The truth? mRNA never enters the cell's nucleus, where our DNA lives, so it cannot change your genes. Even some researchers who explored potential DNA integration warn that the risk is no greater than natural mutations we experience daily. Additionally, expert bodies like Australia's Therapeutic Goods Administration have confirmed there's no contamination with extra DNA. Myth 2: They were rushed and unsafe While development was fast, that doesn't mean corners were cut. The COVID-era mRNA vaccines went through thorough testing and regulatory review. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Is What Willl Happen To Your Body When You Eat 3 Eggs Every Day Undo Steps were indeed accelerated or overlapped, but none were skipped. Plus, mRNA tech has been under development for years before the pandemic, allowing fast but careful vaccine creation. Researchers had decades of mRNA vaccine knowledge, and trials followed strict safety rules, just sped up by global urgency. Real-world safety data , collected from millions, confirms that most side effects are mild and temporary, like sore arms or tiredness. Myth 3: They cause 'turbo cancer' or long-term harm Some conspiracy theories claim a sudden wave of aggressive cancers is tied to mRNA shots. This so-called 'turbo cancer' idea is not supported by any cancer research . No evidence links the vaccines to new cancers, progression, or recurrence. According to the US National Cancer Institute, "there is no evidence that COVID-19 vaccines cause cancer, lead to recurrence, or lead to disease progression." Myth 4: mRNA vaccines make you shed spike proteins The theory of " vaccine shedding " comes from live-virus vaccines, not mRNA ones. 'Vaccine shedding' can happen only with certain live virus vaccines, and none of the approved mRNA vaccines are in that category; they carry no virus. Since mRNA vaccines have no live virus, there's no shedding. This doesn't apply to mRNA vaccines. Myth 5: mRNA vaccines affect your fertility or cause birth issues Factually, no evidence supports this. Data and research show mRNA vaccines are safe for people trying to conceive, pregnant individuals, and breastfeeding mothers. In fact, antibodies may even pass to the baby via breast milk, offering protection. Health authorities also confirm there's no evidence linking these vaccines to fertility issues in men or women. Myth 6: They don't prevent transmission or are useless While no vaccine is perfect, COVID-19 mRNA vaccines dramatically reduce the risk of severe illness and death. Contrary to early misconceptions, they also lower the chance of spreading. Myth 7: Serious side effects pile up after vaccination Serious reactions are extremely rare. For example , anaphylaxis happens at around 2–5 per million doses, manageable when monitored properly. And while some cases of myocarditis (heart inflammation) were reported in younger males, the risk is still much lower than from an actual COVID-19 infection, and most people recover fully. Why do these myths still persist? These myths, like altered DNA or 'turbo cancer,' often thrive because of fear, sensational headlines, and the speed of social media. A survey across European nations shows a notable segment of people believe vaccines are poorly tested or risky. But a growing number of people also express confidence in vaccines when presented with clear facts. What real-world data tell us? Even as science affirms mRNA vaccine safety and value, political decisions are affecting their future. The US government recently cut $500 million in funding for mRNA vaccine research, including contracts with Moderna, sparking concern among scientists that this could hinder preparation for future pandemics. Why trust mRNA vaccines? mRNA vaccines were a scientific breakthrough, and they remain safe, effective, and a vital tool in fighting viruses. Despite persisting myths and scares around them, real-world evidence across large studies shows consistent, mild side effects and strong safety of mRNA vaccines. Furthermore, World Health Organization (WHO) and Lancet analyses estimate that mRNA vaccines prevented millions of deaths around the world. Beyond COVID, mRNA holds promise for flu, cancer, and future outbreaks, even earning a Nobel Prize in 2023. While socio-political challenges and misinformation persist, trusted evidence shows they're more friend than foe. If you want to learn more or still feel uneasy, talk to a doctor or visit reputable sources like the CDC or WHO. This article is intended for general informational purposes only and reflects current scientific understanding as of the time of publication. While the content is based on reputable sources and research, it should not substitute for professional medical advice. Readers with health concerns or questions are encouraged to consult a qualified healthcare provider or trusted health authority. No liability is assumed for any action taken based on the information provided. Hypertension - Separating myths from facts
